Return on average equity - 5 year average | - |
Net Income/employee - trailing 12 month | 20,87,483.00 |
Revenue/employee - most recent fiscal year | 7,99,20,970.00 |
Return on investment - most recent fiscal year | 9.70 |
Return on average assets - most recent fiscal year | 4.44 |
Receivables turnover - most recent fiscal year | 4.54 |
Return on investment - trailing 12 month | 10.15 |
Return on average assets - trailing 12 month | 4.28 |
Inventory turnover - most recent fiscal year | 5.27 |
Inventory turnover - trailing 12 month | 4.53 |
Revenue/employee - trailing 12 month | 7,65,88,880.00 |
Return on average assets - 5 year average | - |
Net Income/employee - most recent fiscal year | 19,75,052.00 |
Return on average equity - trailing 12 month | 11.25 |
Receivables turnover - trailing 12 month | 4.02 |
Asset turnover - most recent fiscal year | 1.80 |
Asset turnover - trailing 12 month | 1.57 |
Return on average equity - most recent fiscal year | 10.77 |
Return on investment - 5 year average | - |
Sudarshan Pharma Industries Dividend Sudarshan Pharma Industries Bonus Sudarshan Pharma Industries News Sudarshan Pharma Industries AGM Sudarshan Pharma Industries Rights Sudarshan Pharma Industries Splits Sudarshan Pharma Industries Board Meetings Sudarshan Pharma Industries Shareholdings Sudarshan Pharma Industries Profit Loss Sudarshan Pharma Industries Balance Sheet Sudarshan Pharma Industries Cashflow Sudarshan Pharma Industries Q1 Results Sudarshan Pharma Industries Q2 Results Sudarshan Pharma Industries Q3 Results Sudarshan Pharma Industries Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks